229 related articles for article (PubMed ID: 31463696)
21. Clinical and prognostic role of annexin A2 in multiple myeloma.
Seckinger A; Meissner T; Moreaux J; Depeweg D; Hillengass J; Hose K; Rème T; Rösen-Wolff A; Jauch A; Schnettler R; Ewerbeck V; Goldschmidt H; Klein B; Hose D
Blood; 2012 Aug; 120(5):1087-94. PubMed ID: 22705595
[TBL] [Abstract][Full Text] [Related]
22. Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer.
Murphy AG; Foley K; Rucki AA; Xia T; Jaffee EM; Huang CY; Zheng L
Oncotarget; 2017 Dec; 8(63):106405-106414. PubMed ID: 29290958
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
24. Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer.
Jung H; Kim JS; Kim WK; Oh KJ; Kim JM; Lee HJ; Han BS; Kim DS; Seo YS; Lee SC; Park SG; Bae KH
Cell Death Dis; 2015 Jan; 6(1):e1606. PubMed ID: 25611381
[TBL] [Abstract][Full Text] [Related]
25. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
Gocheva V; Naba A; Bhutkar A; Guardia T; Miller KM; Li CM; Dayton TL; Sanchez-Rivera FJ; Kim-Kiselak C; Jailkhani N; Winslow MM; Del Rosario A; Hynes RO; Jacks T
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5625-E5634. PubMed ID: 28652369
[TBL] [Abstract][Full Text] [Related]
26. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
[TBL] [Abstract][Full Text] [Related]
27. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
[TBL] [Abstract][Full Text] [Related]
29. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
30. Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma.
Wei DM; Dang YW; Feng ZB; Liang L; Zhang L; Tang RX; Chen ZM; Yu Q; Wei YC; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 50(3):823-840. PubMed ID: 30355917
[TBL] [Abstract][Full Text] [Related]
31. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
Yang Z; Ni W; Cui C; Fang L; Xuan Y
Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
[TBL] [Abstract][Full Text] [Related]
32. Prognostic features of Annexin A2 expression in prostate cancer.
Tan SH; Young D; Chen Y; Kuo HC; Srinivasan A; Dobi A; Petrovics G; Cullen J; Mcleod DG; Rosner IL; Srivastava S; Sesterhenn IA
Pathology; 2021 Feb; 53(2):205-213. PubMed ID: 32967771
[TBL] [Abstract][Full Text] [Related]
33. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
[TBL] [Abstract][Full Text] [Related]
34. The clinical significance of tenascin-C splice variant expression in chondrosarcoma.
Ghert MA; Jung ST; Qi W; Harrelson JM; Erickson HP; Block JA; Scully SP
Oncology; 2001; 61(4):306-14. PubMed ID: 11721178
[TBL] [Abstract][Full Text] [Related]
35. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and diagnostic significance of annexin A2 in colorectal cancer.
Yang T; Peng H; Wang J; Yang J; Nice EC; Xie K; Huang C
Colorectal Dis; 2013 Jul; 15(7):e373-81. PubMed ID: 23489866
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma.
Ma RL; Shen LY; Chen KN
Oncol Rep; 2014 May; 31(5):2157-64. PubMed ID: 24626613
[TBL] [Abstract][Full Text] [Related]
38. Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
Sundquist E; Kauppila JH; Veijola J; Mroueh R; Lehenkari P; Laitinen S; Risteli J; Soini Y; Kosma VM; Sawazaki-Calone I; Macedo CC; Bloigu R; Coletta RD; Salo T
Br J Cancer; 2017 Feb; 116(5):640-648. PubMed ID: 28095396
[TBL] [Abstract][Full Text] [Related]
39. Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway.
Paron I; Berchtold S; Vörös J; Shamarla M; Erkan M; Höfler H; Esposito I
PLoS One; 2011; 6(6):e21684. PubMed ID: 21747918
[TBL] [Abstract][Full Text] [Related]
40. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression.
Abdelraouf EM; Hussein RRS; Shaaban AH; El-Sherief HAM; Embaby AS; Abd El-Aleem SA
Life Sci; 2022 Nov; 308():120967. PubMed ID: 36116530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
